Fei Yee Lee

Ms. Fei Yee Lee

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2014 in International Journal of Food Properties
Verified
Journal Article
Closed access
FLFei Yee Lee
Fei Yee Lee
Thet Thet HtarThet Thet Htar
Thet Thet Htar
GAGabriel Akowuah
Gabriel Akowuah
Attenuated total reflectance Fourier transform infrared spectrometric method for determination of crocin in commercial saffron samples was studied. Calibration models were built based on the peaks at spectral region of 1700–900 cm−1 and spectral wavenumbers with correlation coefficient (r) greater than 0.99 were selected for quantification of crocin in the samples. The quantitative analysis of samples by attenuated total reflectance Fourier transform infrared was tested against reference UV-visible spectrophotometry method. Considerable correlation (r = 0.95) between both methods in prediction of crocin content among the saffron samples indicated that the proposed methodology has the potential application as a rapid screening tool.

Verified
Journal Article
Open access
PDF file
FLFei Yee Lee
Fei Yee Lee
FIFarida Islahudin
Farida Islahudin
ANAina Yazrin Ali Nasiruddin
Aina Yazrin Ali Nasiruddin
AGAbdul Halim Abdul Gafor
Abdul Halim Abdul Gafor
HWHin-Seng Wong
Hin-Seng Wong
MMMohd Makmor-Bakry
Mohd Makmor-Bakry
Personalised medicine is potentially useful to delay the progression of chronic kidney disease (CKD). The aim of this study was to determine the effects of CYP3A5 polymorphism in rapid CKD progression. This multicentre, observational, prospective cohort study was performed among adult CKD patients (≥18 years) with estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2, who had ≥4 outpatient, non-emergency eGFR values during the three-year study period. The blood samples collected were analysed for CYP3A5*3 polymorphism. Rapid CKD progression was defined as eGFR decline of >5 mL/min/1.73 m2/year. Multiple logistic regression was then performed to identify the factors associated with rapid CKD progression. A total of 124 subjects consented to participate. The distribution of the genotypes adhered to the Hardy–Weinberg equilibrium (X2 = 0.237, p = 0.626). After adjusting for potential confounding factors via multiple logistic regression, the factors associated with rapid CKD progression were CYP3A5*3/*3 polymorphism (adjusted Odds Ratio [aOR] 4.190, 95% confidence interval [CI]: 1.268, 13.852), adjustments to antihypertensives, young age, dyslipidaemia, smoking and use of traditional/complementary medicine. CKD patients should be monitored closely for possible factors associated with rapid CKD progression to optimise clinical outcomes. The CYP3A5*3/*3 genotype could potentially be screened among CKD patients to offer more individualised management among these patients.

1 October 2018 in Transplantation Proceedings
Verified
Journal Article
Closed access
CCC.L. Choong
C.L. Choong
HWHin-Seng Wong
Hin-Seng Wong
FLFei Yee Lee
Fei Yee Lee
CLC.K. Lee
C.K. Lee
JKJ.V. Kho
J.V. Kho
TVT. Vikneswaran
T. Vikneswaran

22 November 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NRNorazida Ab Rahman
Norazida Ab Rahman
MLMing Tsuey Lim
Ming Tsuey Lim
FLFei Yee Lee
Fei Yee Lee
WWWee Kee Wo
Wee Kee Wo
HYHee Sheong Yeoh
Hee Sheong Yeoh
SSSheamini Sivasampu
Sheamini Sivasampu
This study assessed the association between COVID-19 vaccines, SARS-CoV-2 infection and the risk of thrombocytopenia and venous thromboembolism (VTE). This self-controlled case series study used hospital records between 1st February 2021 and 28th February 2022 linked to the national immunisation registry and COVID-19 surveillance data in Malaysia. Conditional Poisson regression was used to estimate incidence rate ratios (IRR) of events in the risk period (day 1–21 post-exposure) relative to control period with the corresponding 95% confidence interval (CI) adjusted for calendar period. We found no significant increased risk of thrombocytopenia in 1–21 days following BNT162b2, CoronaVac and ChAdOx1 vaccines while the risk was increased following SARS-CoV-2 infection (IRR 15.52, 95% CI 13.38–18.00). Similarly, vaccination with BNT162b2, CoronaVac, or ChAdOx1 was not associated with an increased risk of VTE during the 1–21 days risk period. SARS-CoV-2 infection was associated with increased risk of VTE (IRR 39.84, 95% CI 27.45–32.44). Our findings showed low event rates of thrombocytopenia and VTE following booster vaccination with comparable safety profiles between those who received homologous and heterologous booster combinations. Our findings showed the risk of thrombocytopenia and VTE was not increased after COVID-19 vaccination while the risks were substantially higher after SARS-CoV-2 infection.

1 December 2020 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
FLFei Yee Lee
Fei Yee Lee
HWHin‐Seng Wong
Hin‐Seng Wong
HCHuan‐Keat Chan
Huan‐Keat Chan
NANorleen Mohamed Ali
Norleen Mohamed Ali
MHMuhammad Radzi Abu Hassan
Muhammad Radzi Abu Hassan
NMNoor Aliza Binti Abd Mutalib
Noor Aliza Binti Abd Mutalib

27 May 2021 in Indian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
YLYeen Chin Leow
Yeen Chin Leow
ARApril Camilla Roslani
April Camilla Roslani
RXRuben Gregory Xavier
Ruben Gregory Xavier
FLFei Yee Lee
Fei Yee Lee